Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
Public ClinicalTrials.gov record NCT00570063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Double-blind, Randomized, Fixed Dose, Parallel Group, 3-week Inpatient Treatment Study To Evaluate The Safety, Efficacy And Pharmacokinetics Of Pf-02545920 Compared With Placebo In The Treatment Of Acute Exacerbation Of Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of an investigational compound PF-02545920 for the treatment of schizophrenia. PF-02545920 will be more effective than placebo in reducing symptoms associated with schizophrenia.
Study identification
- NCT ID
- NCT00570063
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Actual)
- Primary completion
- Feb 18, 2008 (Actual)
- Completion
- Feb 18, 2008 (Actual)
- Last update posted
- Dec 20, 2017
2007 – 2008
United States locations
- U.S. sites
- 10
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Clinical Trials Medical Group, Inc. | Glendale | California | 91206 | — |
| Glendale Adventist Medical Center | Glendale | California | 91206 | — |
| Telecare-Cresta Loma | Lemon Grove | California | 91945 | — |
| California Clinical Trials Medical Group | Paramount | California | 90723 | — |
| LaPaz Geropsychiatric Center | Paramount | California | 90723 | — |
| California Clinical Trials Medical Group | San Diego | California | 92123 | — |
| Connecticut Mental Health Center-Yale University, Clinical Neuroscience Research Unit | New Haven | Connecticut | 06519 | — |
| CRI Worldwide, LLC | Willingboro | New Jersey | 08046 | — |
| St. Anthony Hospital | Oklahoma City | Oklahoma | 73101 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00570063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00570063 live on ClinicalTrials.gov.